Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Iskalni niz: išči po
išči po
išči po
išči po

Možnosti:
  Ponastavi


Iskalni niz: "ključne besede" (zdravljenje) .

1 - 10 / 721
Na začetekNa prejšnjo stran12345678910Na naslednjo stranNa konec
1.
2.
3.
Magnetic nanoparticles as targeted delivery systems in oncology
Sara Prijič, Gregor Serša, 2011, pregledni znanstveni članek

Ključne besede: nanodelci, magnetni nanodelci, onkologija, zdravljenje
Objavljeno v DiRROS: 18.03.2024; Ogledov: 20; Prenosov: 5
.pdf Celotno besedilo (896,04 KB)

4.
Lymphedema following cancer therapy in Slovenia : a frequently overlooked condition?
Tanja Planinšek Ručigaj, Nada Kecelj, Vesna Tlaker Žunter, 2010, izvirni znanstveni članek

Povzetek: Introduction. Secondary lymphedema following cancer therapy is a frequent, often painful, quality of life disturbing condition, reducing the patients' mobility and predisposing them to complications, e.g. infections and malignancies. The critical aspect of lymphedema therapy is to start as soon aspossible to prevent the irreversible tissue damage. Patients and methods. Weperformed a retrospective study of patients with lymphedema, treated at the Department of Dermatovenereology, University Medical Center Ljubljana, from January 2002 to June 2010. The patientsć demographic and medical data were collected, including type of cancer, type and stage of lymphedema, and time tofirst therapy of lymphedema. The number of referred patients with lymphedema following the therapy of melanoma, breast cancer, and uterine/cervical cancer, was compared to the number of patients expected to experience lymphedema following cancer therapy, calculated from the incidence reported in the literature. Results. In the period of 8.5 years, 543 patients (432 females, 112 males) with lymphedema were treated. The results show that probably many Slovenian patients with secondary lymphedema following cancer therapy remain unrecognized and untreated or undertreated. In the majority of our patients, the management of lymphedema was delayedč on average, the patients first received therapy for lymphedema 3.6 years after the first signsof lymphedema. Conclusions. To avoid a delay in diagnosis and therapy, and the complications of lymphedema following cancer therapy, the physician should actively look for signs or symptoms of lymphedema during the follow-up period, and promptly manage or refer the patients developing problems.
Ključne besede: rak (medicina), zdravljenje, limfedem
Objavljeno v DiRROS: 18.03.2024; Ogledov: 16; Prenosov: 5
.pdf Celotno besedilo (416,52 KB)

5.
Imaging findings in bisphosphonate-induced osteonecrosis of the jaws
Katarina Šurlan Popović, Miha Kočar, 2010, izvirni znanstveni članek

Ključne besede: rak (medicina), bisfosfonati, radiologija, zdravljenje, čeljustnica, nekroze, diagnostika
Objavljeno v DiRROS: 18.03.2024; Ogledov: 15; Prenosov: 5
.pdf Celotno besedilo (737,45 KB)

6.
Rak jajčnikov : kaj morate vedeti o bolezni
Brigita Gregorič, Erik Škof, Breda Škrbinc, 2023, ni določena

Ključne besede: dejavniki tveganja, simptomi, diagnostika, zdravljenje, neželeni učinki
Objavljeno v DiRROS: 06.03.2024; Ogledov: 57; Prenosov: 18
.pdf Celotno besedilo (1,84 MB)

7.
8.
9.
Residual carcinoma of the uterine cervix after low-dose preoperative intracavitary irradiation
Albert Peter Fras, 1995, izvirni znanstveni članek

Ključne besede: rak (medicina), maternični vrat, zdravljenje
Objavljeno v DiRROS: 15.01.2024; Ogledov: 140; Prenosov: 36
.pdf Celotno besedilo (253,10 KB)

10.
Transcatheter occlusion of patent ductus arteriosus in adults
Dušan Pavčnik, Pavel Berden, Mirta Koželj, 1995, strokovni članek

Ključne besede: ožilje, kirurgija, kateter, zdravljenje
Objavljeno v DiRROS: 15.01.2024; Ogledov: 133; Prenosov: 45
.pdf Celotno besedilo (203,93 KB)

Iskanje izvedeno v 0.35 sek.
Na vrh